502 related articles for article (PubMed ID: 30119869)
21. Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis.
Napolitano M; Fabbrocini G; Scalvenzi M; Nisticò SP; Dastoli S; Patruno C
Dermatitis; 2020; 31(1):81-84. PubMed ID: 31517666
[TBL] [Abstract][Full Text] [Related]
22. Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
Vakharia PP; Chopra R; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Simpson EL; Silverberg JI
Br J Dermatol; 2018 Apr; 178(4):925-930. PubMed ID: 29048751
[TBL] [Abstract][Full Text] [Related]
23. Validity and reliability of itch assessment scales for chronic pruritus in adults: A prospective multicenter study.
Jang YH; Kim SM; Eun DH; Park KD; Park GH; Kim BS; Li K; Park CO; Kim HO; Kim HS; Jang MS; Doh EJ; Lee DH; Lee YW; Kim DW; Kim SJ
J Am Acad Dermatol; 2020 Jan; 82(1):80-86. PubMed ID: 31255747
[TBL] [Abstract][Full Text] [Related]
24. Clinical aspects and management of chronic itch.
Zeidler C; Raap U; Witte F; Ständer S
J Allergy Clin Immunol; 2023 Jul; 152(1):1-10. PubMed ID: 37178730
[TBL] [Abstract][Full Text] [Related]
25. Symptom burden of patients with moderate-to-severe atopic dermatitis.
Egeberg A; Anderson P; Piercy J; Massey L; Cappelleri JC; Encinas GA; Feeney C; Dibonaventura M
Eur J Dermatol; 2021 Dec; 31(6):752-758. PubMed ID: 34935621
[TBL] [Abstract][Full Text] [Related]
26. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada.
de Bruin-Weller M; Gadkari A; Auziere S; Simpson EL; Puig L; Barbarot S; Girolomoni G; Papp K; Pink AE; Saba G; Werfel T; Eckert L
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1026-1036. PubMed ID: 31587373
[TBL] [Abstract][Full Text] [Related]
27. Itch severity and quality of life in patients with pruritus: preliminary validity of a Danish adaptation of the itch severity scale.
Zachariae R; Lei U; Haedersdal M; Zachariae C
Acta Derm Venereol; 2012 Sep; 92(5):508-14. PubMed ID: 22002738
[TBL] [Abstract][Full Text] [Related]
28. Pruritus differences between psoriasis and lichen planus.
Reich A; Welz-Kubiak K; Szepietowski JC
Acta Derm Venereol; 2011 Sep; 91(5):605-6. PubMed ID: 21547340
[No Abstract] [Full Text] [Related]
29. Impact of functional pruritus compared with mild psoriasis on quality of life: a cross-sectional questionnaire study in Turkey.
Altunay IK; Atis G; Esen K; Kucukunal A
Am J Clin Dermatol; 2014 Aug; 15(4):365-70. PubMed ID: 24756248
[TBL] [Abstract][Full Text] [Related]
30. [Prurigo nodularis: its association with dermatoses and systemic disorders].
Mettang T; Vonend A; Raap U
Hautarzt; 2014 Aug; 65(8):697-703. PubMed ID: 25113328
[TBL] [Abstract][Full Text] [Related]
31. Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.
Pezzolo E; Gambardella A; Guanti M; Bianchelli T; Bertoldi A; Giacchetti A; Donini M; Argenziano G; Naldi L
J Am Acad Dermatol; 2023 Aug; 89(2):430-432. PubMed ID: 37150301
[No Abstract] [Full Text] [Related]
32. Influence of Itch and Pain on Sleep Quality in Atopic Dermatitis and Psoriasis.
Kaaz K; Szepietowski JC; Matusiak Ł
Acta Derm Venereol; 2019 Feb; 99(2):175-180. PubMed ID: 30307027
[TBL] [Abstract][Full Text] [Related]
33. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
Simpson EL; Bieber T; Eckert L; Wu R; Ardeleanu M; Graham NM; Pirozzi G; Mastey V
J Am Acad Dermatol; 2016 Mar; 74(3):491-8. PubMed ID: 26777100
[TBL] [Abstract][Full Text] [Related]
34. Burden of skin pain in atopic dermatitis.
Vakharia PP; Chopra R; Sacotte R; Patel KR; Singam V; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
Ann Allergy Asthma Immunol; 2017 Dec; 119(6):548-552.e3. PubMed ID: 29223299
[TBL] [Abstract][Full Text] [Related]
35. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
36. Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Question-naire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris.
Ständer S; Steinke S; Augustin M; Metze D; Loser K; Baeumer D; Sieder C; Luger T
Acta Derm Venereol; 2019 Nov; 99(12):1085-1090. PubMed ID: 31386163
[TBL] [Abstract][Full Text] [Related]
37. The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries.
Brenaut E; Halvorsen JA; Dalgard FJ; Lien L; Balieva F; Sampogna F; Linder D; Evers AWM; Jemec GBE; Gieler U; Szepietowski J; Poot F; Altunay IK; Finlay AY; Salek SS; Szabo C; Lvov A; Marron SE; Tomas-Aragones L; Kupfer J; Misery L
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):157-162. PubMed ID: 29923228
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and disease burden in prurigo nodularis.
Aggarwal P; Choi J; Sutaria N; Roh YS; Wongvibulsin S; Williams KA; Huang AH; Boozalis E; Le T; Chavda R; Gabriel S; Kwatra SG
Clin Exp Dermatol; 2021 Oct; 46(7):1277-1284. PubMed ID: 33969517
[TBL] [Abstract][Full Text] [Related]
39. Chronic Pruritus of Unknown Origin: Clinical Profile and Disease-Related Burden.
Pereira MP; Farcas A; Zeidler C; Ständer S
Acta Derm Venereol; 2021 Sep; 101(9):adv00550. PubMed ID: 34405244
[TBL] [Abstract][Full Text] [Related]
40. Psoriasis-associated itch: etiology, assessment, impact, and management.
Pithadia DJ; Reynolds KA; Lee EB; Wu JJ
J Dermatolog Treat; 2020 Feb; 31(1):18-26. PubMed ID: 30663443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
